ARMCX Family Gene Expression Analysis and Potential Prognostic Biomarkers for Prediction of Clinical Outcome in Patients with Gastric Carcinoma

Figure 6

Nomogram for predicting the 1-, 3-, 5-, and 10-year events (death) with risk scores and clinical parameters. The high expression levels of ARMCX1 and ARMCX2, age of the patient (>60 years old), and advanced tumor stage established a prognostic feature that conduced to the highest risk for poor OS.